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Summary
An epigenetic profile defining the DNA methylation age (DNAm
age) of an individual has been suggested to be a biomarker of
aging, and thus possibly providing a tool for assessment of health
and mortality. In this study, we estimated the DNAm age of 378
Danish twins, age 30–82 years, and furthermore includeda10-year
longitudinal study of the 86 oldest-old twins (mean age of 86.1 at
follow-up), which subsequently were followed for mortality for
8 years. We found that the DNAm age is highly correlated with
chronological age across all age groups (r = 0.97), but that the rate
of changeof DNAmagedecreaseswith age. The resultsmay in part
be explainedby selectivemortality of thosewithahighDNAmage.
This hypothesis was supported by a classical survival analysis
showing a 35% (4–77%) increased mortality risk for each 5-year
increase in the DNAm age vs. chronological age. Furthermore, the
intrapair twin analysis revealed a more-than-double mortality risk
for the DNAm oldest twin compared to the co-twin and a ‘dose–
response pattern’ with the odds of dying first increasing 3.2
(1.05–10.1) times per 5-year DNAm age difference within twin
pairs, thus showing a stronger association of DNAm age with
mortality in the oldest-old when controlling for familial factors. In
conclusion, our results support that DNAm age qualifies as a
biomarker of aging.
Key words: biological age; biomarker; DNA methylation;
epigenetic clock; mortality; twins.
Introduction
Agrowing body of evidence documents that epigenetic phenomena, such
as DNA methylation, are implicated in disease development and rate of
aging(Maunakeaet al.,2010;Huidobroet al.,2013;Murphy&Mill,2014).
Due to the advent of array technologies, such as the Infinium
HumanMethylation27 and HumanMethylation450 BeadChips, DNA
methylation levels of CG dinucleotides (CpGs) across the genome are
now easily accessible markers. Such array-based studies of the genome-
wide methylation landscape in humans have demonstrated a changing
pattern throughout the entire lifetime: changes that are influenced by
various parameters such as the genetic background, environmental
exposures, and simple epigenetic drift or loss of maintenance of the
epigeneticmarks (Alischet al., 2012;Bellet al., 2012; Florathet al., 2014).
Several recent studies have made use of the age-related changes in
methylation profiles to construct DNA methylation signatures, a DNA
methylation age (DNAm age) or ‘epigenetic clock’, with impressively
high correlations with chronological age, of about 0.7 or greater. These
indexes have been based on profiles from whole blood (Hannum et al.,
2013; Weidner et al., 2014), saliva samples (Bocklandt et al., 2011), or
samples across multiple tissues (Koch & Wagner, 2011; Horvath, 2013).
Considering that methylation profiles are modifiable by lifestyle and
other environmental influences, it has been proposed that DNAm age is
a biomarker of aging, that is, that DNAm age provides a better estimate
of biological age than chronological age and is associated with current
and future health and mortality (Hannum et al., 2013; Weidner et al.,
2014). Along this line of thought, Marioni et al. (2015a) recently tested
whether the deviation of DNAm age from chronological age, ΔAge, was
associated with all-cause mortality in four large study cohorts (mean
ages 66–79 years) with mean time to death ranging from 7.2 to
10.5 years. In a meta-analysis across the four cohorts, the authors found
that a 5-year increase in ΔAge was associated with a moderately
increased mortality risk of 21% using the Hannum index and 11% using
the Horvath index, independent of chronological age and other known
risk factors (Marioni et al., 2015a).
In this study, we estimated DNAm age using the frequently applied
Horvath prediction model and confirmed it using the Hannum prediction
model. The study sample consisted of 378 twins aged 30–82 years from
the Danish Twin Registry. The oldest 86 twins (mean age 76.2 years at
intake) were resampled in a 10-year follow-up study and had methy-
lation age determined again at mean age 86.1 years. The mortality in
this sample was subsequently followed for 8 years. The twin design
enabled us to control partly for genetic and rearing environment in the
mortality study.
Based on these cross-sectional and longitudinal data, we found that
the association between DNAm age and chronological age diminished
substantially with age. The finding may in part stem from selective
mortality, as DNAm age was associated with mortality among the oldest-
old.
Results
Table 1 outlines the basic characteristics of the study populations: the
cross-sectional data from young and middle-aged twins drawn from the
birthweight-discordant twin study and the cross-sectional and longitu-
dinal data from the study of elderly twins. As the birthweight-discordant
study group is a selected sample, we tested for any linear or nonlinear
relationship between birthweight and DNAm age and found no
association (P’s > 0.25, data not shown).
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In Fig. 1a, the estimated Horvath DNAm age is plotted against the
chronological age for the three groups. The overall correlation
coefficient, through all age groups, was 0.97. We fitted a cubic
smoothing spline to visualize the relationship between DNAm age and
chronological age. As Fig. 1a shows, at younger ages the DNAm age
increases in line with the chronological age; however, at older ages the
increase in DNAm with chronological age decelerates. The Horvath
index predicted age slightly lower than chronological age
(mean = 1.4 years lower, SD = 5.6). The Hannum index supported
the general picture (results not shown), although these estimates were
higher than chronological age through the entire age range
(mean = 3.6 years higher, SD = 5.4).
To further explore the DNAm age deceleration, we separately
regressed DNAm age onto chronological age for the young and middle-
aged cross-sectional age groups as well as for the longitudinal sample of
oldest-olds (see Fig. S1, Supporting information). This analysis shows that
DNAm age is closely related to actual age in the young population with
DNAm age increasing 0.97 years (CI95: 0.65–1.29) for each year
increment in chronological age. However, the average change of
methylation age by actual age attenuates in the middle-aged populations
(0.80 years, CI95: 0.59–1.00), and even more so in the longitudinal
analysis of the oldest population (0.65 years, CI95: 0.51–0.78).
In Fig. 1b, the trajectories for each longitudinally followed individual
are plotted, with the individual lines grouped by color into four classes of
DNAm age increase over the approximately 10-year increase in
chronological time, ranging from < 5 years (slow DNAm agers) (22%),
over 5–8 years (41%) and 8–12 years (33%), to more than 12 years
(faster DNAm agers) (5%).
The apparent decrease in rate of change of DNAm age with
increasing age could be partly due to selective survival of those
individuals that present with a DNAm age younger than chronological
age. This hypothesis was supported by a Cox proportional hazard
analysis of the second (follow-up) assessment of the Horvath DNAm
age. Of the 86 individuals, 55 had died during the mean mortality
follow-up time of 5.7 years (range 0.3–7.9), and the hazard ratio per
5-year increase in DNAm age vs. chronological age was estimated to
be 1.35 (CI95: 1.04–1.77, P = 0.019). The Hannum predictor gave a
similar estimate, although nonsignificant (1.35, CI95: 0.94–1.95,
P = 0.106).
To control partly for genetic and environmental factors shared
between a twin pair, we performed intrapair mortality analysis of the old
twins from the second assessment onwards for 8 years. The two plots in
Fig. 2 depict the mortality according to intrapair DNAm age difference as
assessed by the start of the mortality follow-up time on the one side, and
difference in change over the preceding 10 years on the other side. At
the end of the follow-up, 36 of the 43 twin pairs had at least one
deceased twin, and in these 36 pairs, the twin partner with the higher
DNAm age died first in 25 cases (Probability = 0.69, CI95: 0.52–0.84)
corresponding to a more-than-double risk of dying first for the DNAm
oldest co-twin. The probability increased with increasing discordance in
DNAm age within twin pairs in the cross-sectional estimation, whereas
the size of the intrapair difference in change of methylation age vs.
actual age over the 10 preceding years did not affect the probability of
dying first (Fig. 2). In addition, a logistic regression analysis showed that
while accounting for cell composition of the 36 twin pairs, the odds of
dying first increased 3.2 (1.05–10.1) times for a 5-year DNAm age
difference within twin pairs. The corresponding estimate using the
Hannum model was 2.1 (0.9–4.8).
Discussion
Using a sample of 378 twins, age 30–82 years, we confirm the previous
findings that DNAm age is correlated well with chronological age in
young and middle-aged individuals with a tendency of an underestima-
tion with increasing age. This finding is supported by data from Marioni
et al. (2015b) who find that the Horvath clock underestimates the age in
older individuals by approximately 4 years.
The lower yearly increase in DNAm age with increasing age may be
partly explained by selective mortality; that is, those with high DNAm
have the highest mortality, and hence, the surviving population will
increasingly comprise slow agers with low methylation ages making the
DNAm age curve level off when plotted against chronological age in a
cross-sectional study (Christensen et al., 2008; Vaupel, 2010). The less-
than-perfect relationship in the longitudinal study of oldest-olds also
suggests that methylation age is advancing at a slower rate than
chronological age. In principle, it is possible that this phenomenon is
related to an evolution of hematopoietic oligoclonality at extreme ages,
which was recently suggested (Holstege et al., 2014), where the
peripheral blood cells in long-living individuals are derived mainly from
clones with a younger DNAm age.
In the mortality analysis, we confirmed the hypothesis of selective
mortality in a classical survival analysis showing that a 5-year higher
DNAm age than chronological age was significantly associated with a
35% increase in mortality risk. Due to the twin setup of this study, we
were further able to substantiate this with an intrapair twin analysis,
which demonstrated that among these old twins, the twin partner with
the higher DNAm age in 69% of cases were the twin that died first,
which corresponds to a more-than-double risk for the DNAm oldest twin
compared to the co-twin. Moreover, we saw a clear tendency of a dose-
effect of accelerated methylation age, as the larger the intrapair
difference in DNAm age, the higher the probability of mortality in the
DNAm oldest twin. These findings thus support that DNAm age is a
useful and powerful biomarker of aging.
Our findings are in line with the only other study thus far that has
explored the possible association between DNAm age and mortality
Table 1 Characteristics of the study populations
Data Sex Age (SD)
Horvath
methylation
age (SD)
Age
difference
(SD) N
Cross-sectional
(N = 292)
Male 47.82 (15.40) 48.76 (14.18) 0.95 (4.82) 152
Female 49.45 (15.54) 49.31 (13.67) 0.14 (5.41) 140
Young
(N = 142)
Male 33.18 (1.86) 35.88 (3.84) 2.70 (3.79) 78
Female 32.98 (2.17) 35.77 (4.87) 2.78 (3.98) 64
Middle-aged
(N = 150)
Male 63.24 (4.06) 62.34 (5.99) 0.90 (5.10) 74
Female 63.32 (4.18) 60.71 (6.17) 2.61 (5.25) 76
Longitudinal
(N = 172)
Male 81.70 (5.28) 77.94 (5.63) 3.76 (4.63) 48
Female 80.97 (5.27) 76.29 (5.86) 4.68 (5.23) 124
Intake
(N = 86)
Male 76.75 (1.73) 74.37 (3.40) 2.39 (3.73) 24
Female 76.02 (1.76) 72.65 (4.51) 3.37 (4.88) 62
Follow-up
(N = 86)
Male 86.64 (1.74) 81.51 (4.70) 5.13 (5.10) 24
Female 85.92 (1.77) 79.94 (4.67) 5.98 (5.29) 62
Min Q1 Mean Median Q3 Max
Follow-up interval
(years)
9.47 9.55 9.90 10.01 10.09 10.54
Methylation age
difference (years)
0.51 5.14 7.25 6.93 9.26 17.56
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(Marioni et al., 2015a), although the effect estimates were stronger
(35% vs. 11% for the Horvath clock and 21% for the Hannum clock,
respectively). With a combined sample size of more than 4000
individuals, from four independent cohorts of older people, and with a
much higher number of deaths (> 800), the study from Marioni et al.
was considerably larger than ours. However, the use of the powerful
twin design in the present study may explain the relatively stronger
association, which is likely to be due to the elimination of genetic and
early life confounding in the intrapair analysis. Individuals may already
very early in life have a DNAm age that deviates from the mean due to
genetic factors and/or rearing environment, and the intrapair analyses
will to some degree control for such early-life differences.
The combined results from the mortality studies support the
potential of blood methylation age as a biomarker of future general
health and all-cause mortality. In addition, the ability of the DNAm
age index to discriminate between slowed and accelerated rate of
aging holds potential for identifying genes, pathways, and regulatory
mechanisms of importance for disease development and age-related
decline in biological functioning. To this end, studies are now
emerging which demonstrate that an accelerated DNAm age may
be linked to disease development. For instance, a modest cross-
sectional association between accelerated methylation age and lower
cognition, weaker grip strength, and poorer lung function was
suggested by Marioni et al. (2015b), although they could not
document that DNAm age at intake could predict future decline in
any of the measured parameters. In addition, a significantly acceler-
ated DNAm age of both blood and brain tissue was seen in trisomy
21 individuals, perhaps mirroring the premature aging conditions
often experienced by these individuals (Horvath et al., 2015a). Further
exploring the possible importance of tissue specific aging, obesity has
been associated with an increased biological age of the liver (Horvath
et al., 2014). And recently, Horvath et al. (2015b) applied the
‘epigenetic clock’ to a number of tissues and found that the
cerebellum ages at an increasingly slower rate in 80+ years individuals
compared to other brain regions. While the conclusions that can be
drawn from this finding are still highly speculative, it does suggest
that DNAm age of also specific tissues could be a sign of biological
age (Horvath et al., 2015b).
In conclusion, we report a leveling off of the correlation between
DNAm age and chronological age in old cohorts, which is likely to reflect
that individuals reaching advanced ages have a more healthy aging
profile. The association with mortality risk seen in the old twins when
adjusting for familial factors adds considerable evidence to support the
hypothesis that DNAm age can discriminate between slow and fast
agers, consistent with the hypothesis that DNAm age is a proxy for
underlying mechanisms of aging.
Experimental procedures
Study samples
The study samples were drawn from two surveys conducted at the
Danish Twin Registry (Skytthe et al., 2013) for which data on DNA
methylation were already available: the Longitudinal Study of
Aging Danish Twins (LSADT) (McGue & Christensen, 2007) and a
study of the Extremely Birth Weight Discordant Twins (Frost et al.,
2012).
The Longitudinal Study of Aging Danish Twins includes all Danish
twins 70 years of age or more. The study was initiated in 1995 and
surviving twins were followed-up every second year through 2007
(Christensen et al., 1999; McGue & Christensen, 2007). In 1997 and
2007, whole blood samples were collected from same-sex twin pairs,
and the samples included in the present study consisted of those 18
monozygotic (MZ) pairs and 25 dizygotic (DZ) pairs, which participated in
both the 1997 and the 2007 wave. The age range for LSADT samples
was 73–82 years (mean 76.2) in 1997.
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Fig. 1 Horvath DNAm age against chronological age. (a) Correlation between the methylation age using the Horvath model. The relation is visualized by a smoothing spline.
(b) DNAm age trajectories of each individual in the longitudinal study of oldest-olds. The lines are colored by intervals of slow to fast agers, and the histogram indicates the
distribution within the intervals.
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The second sample consisted of 146 birthweight-discordant MZ twin
pairs collected in 2008–2010 (Frost et al., 2012). The sample was divided
into two age groups, with 142 participants aged 30–37 (mean 33.1)
years and 150 participants aged 57–74 (mean 63.3) years.
Zygosity determination of all twin pairs was based on 12 highly
polymorphic microsatellite markers.
DNA methylation data
DNA was isolated from buffy coats using the salt precipitation method
applying either a manual protocol (Miller et al., 1988) or a semi-
automated protocol based on the Autopure System (Qiagen, Hilden,
Germany). Bisulfite treatment of 500 ng genomic DNA was carried
out with the EZ-96 DNA methylation kit (Zymo Research, Orange
County, CA, USA) following the manufacturer’s protocol.
Genomewide DNA methylation was measured using the Infinium
HumanMethylation450K BeadChip (Illumina, San Diego, CA, USA) at
the Leiden University Medical Center and in accordance with the
manufacturer’s instructions. Data preprocessing was performed using
the free R package minfi (Maksimovic et al., 2012), and a DNA
methylation level was summarized for each CpG site by calculating
a ‘beta’ value ranging from 0 to 100%. CpG probes were treated
as missing if the detection P-value > 0.01, and CpG sites with more
than 5% missing data were excluded from the analysis.
DNA methylation data have been deposited in the NCBI GEO
database (http://www.ncbi.nlm.nih.gov/geo/) under accession numbers
GSE61496 and GSE73115.
Statistical analysis
For each twin, we calculated the DNAm age following the protocol of
Horvath (2013) and Hannum et al. (2013). In the case of both the
birthweight-discordant twin sample and the LSADT sample, we visual-
ized the association between chronological age and DNAm age by fitting
a cubic smoothing spline and further estimated correlations by linear
regression.
In the case of the birthweight-discordant twin sample, we
additionally tested the relationship between birthweight and DNAm
age using a linear mixed regression model with birthweight, age, and
sex as fixed effects and twin pairing as a random factor. A
nonlinear relationship between birthweight and DNAm age was
assessed by converting birthweight into dummy variables according to
its 0.25, 0.5, and 0.75 quantiles and using the first group as
reference.
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Fig. 2 Mortality of the oldest twins
according to intrapair DNAm age difference
at follow-up and difference in change over
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of twins where the DNAm oldest twins died
first (Proportion dead), for all twins and
divided into groups with increasing
intrapair difference. The numbers of twin
pairs in each group are given in brackets,
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In the case of the LSADT, we estimated the population average
(marginal) and within-twin pair (conditional) association of DNAm age
with mortality. The twins included in the mortality study all partic-
ipated in the 10-year follow-up, and therefore, the mortality assess-
ment started after the follow-up sample was drawn. In all survival
analyses, the possible effect of cell composition was estimated and
adjusted for by the approach proposed by Houseman et al. (2012). To
assess the conditional influence of estimated methylation age, first,
we computed the proportion of the co-twins with a higher DNAm
age who died first and compared it with the null hypothesis that both
co-twins are equally likely to die first by an exact binomial test.
Second, we used a conditional logistic regression stratified by twin
pairs and adjusted for cell composition to measure the influence of
within-twin pair DNAm age difference on the odds of dying first. To
measure the marginal effect of DNAm age on survival, a Cox
proportional hazards regression stratified by sex and adjusted for cell
composition was employed. As some twins might have died before
they could have been included in the study, all co-twins in the study
were considered left truncated at the age of entering the follow-up.
The Cox regression was performed using a robust sandwich estimator
of standard errors to account for correlation between twin pairs.
Schoenfeld residuals were checked for deviations from the propor-
tional hazards assumption. All statistical analyses were carried out
using R 3.1.3 (R Core Team 2015 - https://www.r-project.org).
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